ProfileGDS4814 / ILMN_1796595
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 78% 80% 79% 77% 78% 81% 78% 77% 78% 79% 79% 77% 79% 79% 79% 78% 78% 78% 81% 78% 78% 78% 78% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)123.07778
GSM780708Untreated after 4 days (C2_1)139.9180
GSM780709Untreated after 4 days (C3_1)133.49979
GSM780719Untreated after 4 days (C1_2)114.06777
GSM780720Untreated after 4 days (C2_2)126.178
GSM780721Untreated after 4 days (C3_2)153.05981
GSM780710Trastuzumab treated after 4 days (T1_1)126.15978
GSM780711Trastuzumab treated after 4 days (T2_1)113.72477
GSM780712Trastuzumab treated after 4 days (T3_1)123.22978
GSM780722Trastuzumab treated after 4 days (T1_2)128.96879
GSM780723Trastuzumab treated after 4 days (T2_2)129.56479
GSM780724Trastuzumab treated after 4 days (T3_2)115.36977
GSM780713Pertuzumab treated after 4 days (P1_1)132.3779
GSM780714Pertuzumab treated after 4 days (P2_1)128.00279
GSM780715Pertuzumab treated after 4 days (P3_1)133.12179
GSM780725Pertuzumab treated after 4 days (P1_2)126.59978
GSM780726Pertuzumab treated after 4 days (P2_2)123.04978
GSM780727Pertuzumab treated after 4 days (P3_2)125.58878
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)162.86581
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)120.82378
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)118.63378
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)126.1278
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)118.98978